Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT04326556
Eligibility Criteria:
Inclusion Criteria:
* Person over 80 years of age consulting in the geriatrics department of Ste-Périne Hospital (Gerontology Consultations, Dr A Hiance- Delahaye, Head of Department Pr J Ankri. Paris XVI), for a standardised geriatric assessment, for any reason, if it does not result in immediate or foreseeable hospitalisation within 2 weeks,
* Living at home or in a residence,
* Subject living in Ile-de-France,
* Subject speaking French; this study requires minimal participation of subjects (wearing sensors, qualitative interview) that does not appear compatible with comprehension problems,
* MMSE Score ≥ 15
* ADL score ≥ 3
* Affiliated with a health insurance plan or eligible,
* Person who has signed an informed and written consent.
Exclusion Criteria:
* Subject whose state of health requires hospitalization within two weeks,
* Subject under guardianship or curatorship,
* Subject living in collective housing (retirement home) or entering an institution within 2 weeks,
* Abundant thoracic hair causing poor contact of the ECG electrodes of the physiological sensor,
* Rejection of patient's contact information, refuses to answer questionnaires and follow-up visits, or refuses to wear sensors, Impossibility, during the initial assessment, to establish at least telephone contact with the caregiver when he or she organizes the home visit,
* Subject already included in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
80 Years
Study:
NCT04326556
Study Brief:
Protocol Section:
NCT04326556